Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Three million members of CVS Caremarks clients now enjoy access to clinical weight loss program with proven results, high satisfaction WOONSOCKET, R.I., March 14, 2025 CVS Health (NYSE: CVS) released compelling data today from the CVS Weight Management TM program in which participants achieved more than 15% weight loss on average, including existing anti-obesity medication users who succeeded in nearly doubling their pre-program weight loss while working with program clinicians on diet and lifestyle.* Before enrolling in the CVS Weight Management program, 70% of members were using a weight management drug without any lifestyle or nutrition support.* The initial results demonstrate improved weight loss and high program satisfaction for CVS Caremark clients' plan members trying a lifestyle-first approach and additional clinical effectiveness and cost savings for members receiving clinical support while taking weight management medications like GLP-1s
Provided the research supporting the use of DSIP nasal spray, some researchers may want to opt for a nasal spray over injection
3.5 The GSH-c4-containing eye drop formulation promotes in vitro damage repair under stress conditions To evaluate the reparative capacity of HA + GSH-C4 on corneal epithelial injury, we conducted an in vitro wound-healing assay using HCEpiC (Figure 4)
Blood vessels widen, making tissues appear red and warm
